Extended Substrate Recognition in Caspase-3 Revealed by High Resolution X-ray Structure Analysis

Journal of Molecular Biology

Volumn 359, Issue 5, 2006, Pages 1378-1388

  Ganesan, Rajkumar ^a   Mittl, Peer R E ^a   Jelakovic, Stjepan ^a   Grütter, Markus G ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

caspase; low barrier hydrogen bond; radiation damage; safety catch; substrate specificity

Indexed keywords

ASPARTIC ACID; CARBON; CASPASE 3; KETONE; PEPTIDE;

ACYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; CRYSTAL STRUCTURE; ENZYME SPECIFICITY; ENZYME SUBSTRATE; ENZYME SUBUNIT; HYDROGEN BOND; MOLECULAR RECOGNITION; PRIORITY JOURNAL; RADIATION INJURY; SITE DIRECTED MUTAGENESIS; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY;

EID: 33745260957     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2006.04.051     Document Type: Article

References (42)

1. Earnshaw W.C., Martins L.M., and Kaufmann S.H. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Ann. Rev. Biochem. 68 (1999) 383-424
2. Grutter M.G. Caspases: key players in programmed cell death. Curr. Opin.Struct. Biol. 10 (2000) 649
3. Riedl S.J., and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nature Rev. Mol. Cell Biol. 5 (2004) 897-907
4. Fuentes-Prior P., and Salvesen G.S. The protein structures that shape caspase activity, specificity, activation and inhibition. Biochem. J. 384 Pt 2 (2004) 201-232
5. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6 (1999) 1028-1042
6. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., et al. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272 (1997) 17907-17911
7. Stennicke H.R., Renatus M., Meldal M., and Salvesen G.S. Internally quenched fluorescent peptide substrates disclose the subsite preferences of human caspases 1, 3, 6, 7 and 8. Biochem. J. 350 (2000) 563-568
8. Mittl P.R.E., Di Marco S., Krebs J.F., Bai X., Karanewsky D.S., Priestle J.P., et al. Structure of recombinant human CPP32 in complex with the tetrapeptide Acetyl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272 (1997) 6539-6547
9. Rotonda J., Nicholson D.W., Fazil K.M., Gallant M., Gareau Y., Labelle M., et al. The three-dimensional structure of apopain/CPP32, a key mediator of apoptosis. Nature Struct. Biol. 3 (1996) 619-625
10. Hardy J.A., Lam J., Nguyen J.T., O'Brien T., and Wells J.A. Discovery of an allosteric site in the caspases. Proc. Natl Acad. Sci. USA 101 (2004) 12461-12466
11. O'Brien T., and Lee D. Prospects for caspase inhibitors. Mini. Rev. Med. Chem. 4 (2004) 153-165
12. Wilson K.P., Black J.A., Thomson J.A., Kim E.E., Griffith J.P., Navia M.A., et al. Structure and mechanism of interleukin-1 beta converting enzyme. Nature 370 (1994) 205-270
13. Carter P., and Wells J.A. Dissecting the catalytic triad of a serine protease. Nature 332 (1988) 564
14. Polgar L., and Asboth B. The basic difference in catalyses by serine and cysteine proteinases resides in charge stabilization in the transition state. J. Theor. Biol. 121 (1986) 323-326
15. Powers J.C., Asgian J.L., Ekici O.D., and James K.E. Irreversible inhibitors of serine, cysteine, and threonine proteases. Chem. Rev. 102 (2002) 4639-4750
16. Schirmeister T., and Klockow A. Cysteine protease inhibitors containing small rings. Mini. Rev. Med. Chem. 3 (2003) 585-596
17. Storer A.C., and Menard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 244 (1994) 486-500
18. Brady K.D., Giegel D.A., Grinnell C., Lunney E., Talanian R.V., Wong W., and Walker N. A catalytic mechanism for caspase-1 and for bimodal inhibition of caspase-1 by activated aspartic ketones. Bioorg. Med. Chem. 7 (1999) 621-631
19. Sulpizi M., Laio A., VandeVondele J., Cattaneo A., Rothlisberger U., and Carloni P. Reaction mechanism of caspases: insights from QM/MM Car-Parrinello simulations. Proteins: Struct. Funct. Genet. 52 (2003) 212-224
20. Aravind L., and Koonin E.V. Classification of the caspase-hemoglobinase fold: detection of new families and implications for the origin of the eukaryotic separins. Proteins: Struct. Funct. Genet. 46 (2002) 355-367
21. Lee D., Long S.A., Adams J.L., Chan G., Vaidya K.S., Francis T.A., et al. Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality. J. Biol. Chem. 275 (2000) 16007-16014
22. Roy S., Bayly C.I., Gareau Y., Houtzager V.M., Kargman S., Keen S.L., et al. Maintenance of caspase-3 proenzyme dormancy by an intrinsic "safety catch" regulatory tripeptide. Proc. Natl Acad. Sci. USA 98 (2001) 6132-6137
23. Gerd W. Analysis of pH-dependent elements in proteins: geometry and properties of pairs of hydrogen-bonded carboxylic acid side-chains. Proteins: Struct. Funct. Bioinformat. 58 (2005) 396-406
24. Perrin C.L., and Nielson J.B. "Strong" hydrogen bonds in chemistry and biology. Annu. Rev. Phys. Chem. 48 (1997) 511-544
25. Blanchard H., Kodandapani L., Mittl P.R., Marco S.D., Krebs J.F., Wu J.C., et al. The three-dimensional structure of caspase-8: an initiator enzyme in apoptosis. Struct. Fold Des. 7 (1999) 1125-1133
26. Watt W., Koeplinger K.A., Mildner A.M., Heinrikson R.L., Tomasselli A.G., and Watenpaugh K.D. The atomic-resolution structure of human caspase-8, a key activator of apoptosis. Struct. Fold Des. 7 (1999) 1135-1143
27. Diederichs K. Some aspects of quantitative analysis and correction of radiation damage. Acta Crystallog. sect. D 62 (2006) 96-101
28. Feeney B., Pop C., Tripathy A., and Clark A.C. Ionic interactions near the loop L4 are important for maintaining the active-site environment and the dimer stability of (pro)caspase 3. Biochem. J. 384 (2004) 515-525
29. Erlanson D.A., Lam J.W., Wiesmann C., Luong T.N., Simmons R.L., DeLano W.L., et al. In situ assembly of enzyme inhibitors using extended tethering. Nature Biotech. 21 (2003) 308
30. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell 104 (2001) 791-800
31. Esther, D., Lenherr, B. A., Grutter, M. G. (2004). Kinetic characterization of caspase-8. Diploma thesis. Department of Biochemistry, University of Zurich (unpublished results).
32. Garcia-Calvo M., Peterson E.P., Rasper D.M., Vaillancourt J.P., Zamboni R., Nicholson D.W., and Thornberry N.A. Purification and catalytic properties of human caspase family members. Cell Death Differ. 6 (1999) 362-369
33. Stennicke H.R., and Salvesen G.S. Caspase assays. Methods Enzymol. 322 (2000) 91-100
34. Leslie A.G.W. Scala. Joint CCP4/ESF-EACMB Newsletter on Protein Crystallography 26 (1992)
35. Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography. Acta Cryst. D50 (1994) 760-763
36. Evans P.R. Data reduction. Proceedings of the CCP4 Study Weekend on Data Collection and Processing (1992), SRC Daresbury Laboratory, Warrington, UK 114-122
37. Kabsch W. Automatic indexing of rotation diffraction patterns. J. Appl. Crystallog. 21 (1988) 67-72
38. Kabsch W. Evaluation of single-crystal X-ray diffraction data from a position-sensitive detector. J. Appl. Crystallog. 21 (1988) 916-924
39. Brunger A.T., Adams P.D., Clore G.M., DeLano W.L., Gros P., Grosse-Kunstleve R.W., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallog. sect. D 54 (1998) 905-921
40. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallog. sect. A 47 (1991) 110-119
41. Sheldrick G.M., and Schneider T.R. SHELXL: high-resolution refinement. Methods Enzymol. 277 (1997) 319-343
42. Laskowski R.A., MacArthur M.W., Moss D.S., and Thornton J.M. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Crystallog. 26 (1993) 283